Research and Development

The Research and Development team at Boundless Bio focuses on discovering and developing novel cancer therapeutics targeting extrachromosomal DNA (ecDNA). Leveraging expertise in drug discovery, precision medicine, bioinformatics, and clinical operations, this multidisciplinary team works together to understand the role of ecDNA in tumorigenesis, resistance, and recurrence, aiming to bring innovative treatments from the lab to clinical trials.